Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seyed-Mohammad Fereshtehnejad

Showing results (1-10 of 200) with videos related to

Pageof 20
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 12, 2025
Distribution, Demography and Migration Pattern of Neurologists in Canada, 1971-2022Seyed-Mohammad Fereshtehnejad
Neurodegenerative Disease Management|September 8, 2016
Strategies to maintain quality of life among people with Parkinson's disease: what works?Seyed-Mohammad Fereshtehnejad
Biomolecules|March 28, 2026
Skin-Based α-Synuclein Deposits Detection Across the Prodromal Continuum of Synucleinopathies: Updated Evidence and PerspectivesSeyed-Mohammad Fereshtehnejad
Parkinson'S Disease|September 17, 2014
Active aging for individuals with Parkinson's disease: definitions, literature review, and modelsSeyed-Mohammad Fereshtehnejad, Johan Lökk
Healthcare (Basel, Switzerland)|December 22, 2023
Challenges of Teleneurology in the Care of Complex Neurodegenerative Disorders: The Case of Parkinson's Disease with Possible SolutionsSeyed-Mohammad Fereshtehnejad, Johan Lökk
Parkinson'S Disease|March 18, 2014
Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonismSeyed-Mohammad Fereshtehnejad, Johan Lökk
Healthcare (Basel, Switzerland)|August 14, 2025
Healthcare Complexities in Neurodegenerative Proteinopathies: A Narrative ReviewSeyed-Mohammad Fereshtehnejad, Johan Lökk
Current Neurology and Neuroscience Reports|March 22, 2017
Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression?Seyed-Mohammad Fereshtehnejad, Ronald B Postuma
Acta Medica Iranica|July 16, 2013
Factors affecting the efficacy of pramipexole in patients with restless legs syndromeMohammad Rezvani, Babak Zamani, Seyed-Mohammad Fereshtehnejad
Drugs & Aging|February 6, 2014
Anti-dementia drugs and co-medication among patients with Alzheimer's disease : investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem)Seyed-Mohammad Fereshtehnejad, Kristina Johnell, Maria Eriksdotter
Pageof 20

Showing results (1-10 of 200) with videos related to

Sort By:
Pageof 20
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 12, 2025
Distribution, Demography and Migration Pattern of Neurologists in Canada, 1971-2022Seyed-Mohammad Fereshtehnejad
Neurodegenerative Disease Management|September 8, 2016
Strategies to maintain quality of life among people with Parkinson's disease: what works?Seyed-Mohammad Fereshtehnejad
Biomolecules|March 28, 2026
Skin-Based α-Synuclein Deposits Detection Across the Prodromal Continuum of Synucleinopathies: Updated Evidence and PerspectivesSeyed-Mohammad Fereshtehnejad
Parkinson'S Disease|September 17, 2014
Active aging for individuals with Parkinson's disease: definitions, literature review, and modelsSeyed-Mohammad Fereshtehnejad, Johan Lökk
Healthcare (Basel, Switzerland)|December 22, 2023
Challenges of Teleneurology in the Care of Complex Neurodegenerative Disorders: The Case of Parkinson's Disease with Possible SolutionsSeyed-Mohammad Fereshtehnejad, Johan Lökk
Parkinson'S Disease|March 18, 2014
Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonismSeyed-Mohammad Fereshtehnejad, Johan Lökk
Healthcare (Basel, Switzerland)|August 14, 2025
Healthcare Complexities in Neurodegenerative Proteinopathies: A Narrative ReviewSeyed-Mohammad Fereshtehnejad, Johan Lökk
Current Neurology and Neuroscience Reports|March 22, 2017
Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression?Seyed-Mohammad Fereshtehnejad, Ronald B Postuma
Acta Medica Iranica|July 16, 2013
Factors affecting the efficacy of pramipexole in patients with restless legs syndromeMohammad Rezvani, Babak Zamani, Seyed-Mohammad Fereshtehnejad
Drugs & Aging|February 6, 2014
Anti-dementia drugs and co-medication among patients with Alzheimer's disease : investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem)Seyed-Mohammad Fereshtehnejad, Kristina Johnell, Maria Eriksdotter
Pageof 20